CATALYST PHARMACEUTICALS INC (CPRX) Stock Earnings & Estimates
NASDAQ:CPRX - US14888U1016 - Common Stock
19.94 USD
-0.68 (-3.3%)
20.27 USD
+0.33 (+1.65%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 214.2M 52.13% | 398.204M 85.90% | 491.734M 23.49% | 572.94M 16.51% | 627.83M 9.58% | 686.53M 9.35% | 760.52M 10.78% | 842.19M 10.74% | 848.99M 0.81% | 909.63M 7.14% | 973.99M 7.08% | |
| EBITDA YoY % growth | 103M 95.82% | 119.693M 16.21% | 232.898M 94.58% | 233.99M 0.47% | 245.4M 4.88% | 317.77M 29.49% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 101.8M 94.27% | 86.812M -14.72% | 195.124M 124.77% | 228.72M 17.22% | 265.36M 16.02% | 319.52M 20.41% | 340.27M 6.49% | 381.21M 12.03% | 427.61M 12.17% | 483.2M 13.00% | 542.09M 12.19% | |
| Operating Margin | 47.53% | 21.80% | 39.68% | 39.92% | 42.27% | 46.54% | 44.74% | 45.26% | 50.37% | 53.12% | 55.66% | |
| EPS YoY % growth | 0.74 100.00% | 0.81 9.46% | 1.31 61.73% | 1.49 13.37% | 1.75 17.86% | 1.84 5.28% | 3.64 97.60% | 4.24 16.53% | 5.24 23.56% | 2.19 -58.17% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.34 -1.50% | 0.27 -39.73% | 0.36 -20.67% | 0.39 -5.46% | 0.43 24.26% | 0.46 73.08% |
| Revenue Q2Q % growth | 139.51M 8.40% | 139.69M -1.50% | 143.8M 1.68% | 153.03M 4.41% | 159.64M 14.43% | 175.61M 25.71% |
| EBITDA Q2Q % growth | 68.924M -13.00% | 54.987M -45.35% | 76.24M 4.69% | 80.099M -6.01% | N/A | N/A |
| EBIT Q2Q % growth | 53.316M 4.73% | 42.329M -32.64% | 55.141M -12.98% | 70.335M 6.09% | 67.504M 26.61% | 73.318M 73.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.41 24.24% | 0.39 | 0.02 | 4.13% |
| Q1 2025 Q2Q % growth | 0.45 136.84% | 0.35 | 0.10 | 29.76% |
| Q4 2024 Q2Q % growth | 0.44 41.94% | 0.35 | 0.09 | 27.41% |
| Q3 2024 Q2Q % growth | 0.35 220.69% | 0.31 | 0.04 | 12.87% |
| Q2 2024 Q2Q % growth | 0.33 -37.74% | 0.27 | 0.06 | 22.55% |
| Q1 2024 Q2Q % growth | 0.19 -26.92% | 0.17 | 0.02 | 12.21% |
| Q4 2023 Q2Q % growth | 0.31 40.91% | 0.27 | 0.04 | 14.69% |
| Q3 2023 Q2Q % growth | -0.29 -245.00% | -0.29 | 0.00 | 0.24% |
| Q2 2023 Q2Q % growth | 0.53 165.00% | 0.36 | 0.17 | 45.96% |
| Q1 2023 Q2Q % growth | 0.26 116.67% | 0.33 | -0.07 | -20.84% |
| Q4 2022 Q2Q % growth | 0.22 144.44% | 0.22 | 0.00 | 1.74% |
| Q3 2022 Q2Q % growth | 0.20 100.00% | 0.19 | 0.01 | 3.20% |
| Q2 2022 Q2Q % growth | 0.20 81.82% | 0.17 | 0.03 | 15.34% |
| Q1 2022 Q2Q % growth | 0.12 71.43% | 0.14 | -0.02 | -13.49% |
| Q4 2021 Q2Q % growth | 0.09 -18.18% | 0.12 | -0.03 | -23.94% |
| Q3 2021 Q2Q % growth | 0.10 -9.09% | 0.11 | -0.01 | -5.73% |
| Q2 2021 Q2Q % growth | 0.11 22.22% | 0.10 | 0.01 | 12.34% |
| Q1 2021 Q2Q % growth | 0.07 -30.00% | 0.09 | -0.02 | -23.75% |
| Q4 2020 Q2Q % growth | 0.11 37.50% | 0.09 | 0.02 | 17.22% |
| Q3 2020 Q2Q % growth | 0.11 -15.38% | 0.10 | 0.01 | 12.34% |
| Q2 2020 Q2Q % growth | 0.09 -10.00% | 0.09 | 0.00 | 3.81% |
| Q1 2020 Q2Q % growth | 0.10 1,100.00% | 0.09 | 0.01 | 13.12% |
| Q4 2019 Q2Q % growth | 0.08 | 0.11 | -0.03 | -24.10% |
| Q3 2019 Q2Q % growth | 0.13 | 0.11 | 0.02 | 15.86% |
| Q2 2019 Q2Q % growth | 0.10 | 0.03 | 0.07 | 292.16% |
| Q1 2019 Q2Q % growth | -0.01 | -0.13 | 0.12 | 92.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 146.563M 19.44% | 143.42M | 3.143M | 2.19% |
| Q1 2025 Q2Q % growth | 141.421M 43.56% | 134.13M | 7.291M | 5.44% |
| Q4 2024 Q2Q % growth | 141.82M 28.26% | 136.88M | 4.94M | 3.61% |
| Q3 2024 Q2Q % growth | 128.695M 25.33% | 125.89M | 2.805M | 2.23% |
| Q2 2024 Q2Q % growth | 122.71M 23.23% | 114.1M | 8.61M | 7.55% |
| Q1 2024 Q2Q % growth | 98.509M 15.40% | 100.09M | -1.581M | -1.58% |
| Q4 2023 Q2Q % growth | 110.568M 81.86% | 108.04M | 2.528M | 2.34% |
| Q3 2023 Q2Q % growth | 102.688M 79.52% | 102.38M | 308K | 0.30% |
| Q2 2023 Q2Q % growth | 99.582M 87.54% | 93.54M | 6.042M | 6.46% |
| Q1 2023 Q2Q % growth | 85.366M 98.06% | 83.249M | 2.117M | 2.54% |
| Q4 2022 Q2Q % growth | 60.8M 58.75% | 59.252M | 1.548M | 2.61% |
| Q3 2022 Q2Q % growth | 57.2M 58.89% | 54.696M | 2.504M | 4.58% |
| Q2 2022 Q2Q % growth | 53.1M 45.88% | 50.197M | 2.903M | 5.78% |
| Q1 2022 Q2Q % growth | 43.1M 42.72% | 43.61M | -510K | -1.17% |
| Q4 2021 Q2Q % growth | 38.3M 23.55% | 38.955M | -655K | -1.68% |
| Q3 2021 Q2Q % growth | 36M 22.87% | 35.28M | 720K | 2.04% |
| Q2 2021 Q2Q % growth | 36.4M 22.97% | 32.138M | 4.262M | 13.26% |
| Q1 2021 Q2Q % growth | 30.2M 3.78% | 32.742M | -2.542M | -7.76% |
| Q4 2020 Q2Q % growth | 31M 2.99% | 30.957M | 43K | 0.14% |
| Q3 2020 Q2Q % growth | 29.3M -5.18% | 32.124M | -2.824M | -8.79% |
| Q2 2020 Q2Q % growth | 29.6M 2.78% | 30.074M | -474K | -1.58% |
| Q1 2020 Q2Q % growth | 29.1M 134.68% | 32.092M | -2.992M | -9.32% |
| Q4 2019 Q2Q % growth | 30.1M | 29.985M | 115K | 0.38% |
| Q3 2019 Q2Q % growth | 30.9M | 33.844M | -2.944M | -8.70% |
| Q2 2019 Q2Q % growth | 28.8M | 18.862M | 9.938M | 52.69% |
| Q1 2019 Q2Q % growth | 12.4M | 1.632M | 10.768M | 659.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.87% | -2.03% | -0.27% | -0.27% |
| Revenue | -1.55% | -1.29% | 0.12% | 0.12% |